Skip to main content

RIVASTIGMINE TARTRATE

NDC 75834-133 · Nivagen Pharmaceuticals, Inc.

Generic nameRIVASTIGMINE TARTRATE
Dosage formCAPSULE
RouteORAL
Active ingredient(s)RIVASTIGMINE TARTRATE
Strength1.5 mg/1
Pharmacologic classCholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
Marketing categoryANDA

Packages

75834-133-05 — 500 CAPSULE in 1 BOTTLE, PLASTIC (75834-133-05)

75834-133-60 — 60 CAPSULE in 1 BOTTLE, PLASTIC (75834-133-60)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

62332-066 — Rivastigmine Tartrate, 62756-145 — Rivastigmine Tartrate, 62756-146 — Rivastigmine Tartrate, 62756-147 — Rivastigmine Tartrate, 62756-148 — Rivastigmine Tartrate, 65862-648 — Rivastigmine Tartrate, 65862-649 — Rivastigmine Tartrate, 65862-650 — Rivastigmine Tartrate, 65862-651 — Rivastigmine Tartrate, 71209-012 — Rivastigmine Tartrate, 71209-013 — Rivastigmine Tartrate, 71209-014 — Rivastigmine Tartrate, 71209-015 — Rivastigmine Tartrate, 72241-011 — Rivastigmine Tartrate, 72241-012 — Rivastigmine Tartrate, 72241-013 — Rivastigmine Tartrate, 72241-014 — Rivastigmine Tartrate, 75834-134 — RIVASTIGMINE TARTRATE, 75834-135 — RIVASTIGMINE TARTRATE, 75834-136 — RIVASTIGMINE TARTRATE, +21 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels